GAITHERSBURG, Md., and PUNE, India, April 10, 2022 — Novavax, Inc. (Nasdaq: NVAX) and Serum Institute of India Pvt. Ltd. are granted emergency use authorization by the Thai FDA for Novavax’ protein-based vaccine.
The vaccine is for active immunization to prevent COVID-19 caused by the SARS-CoV-2 in individuals 18 years of